Takeda Pharmaceutical (TAK) Treasury Shares (2017 - 2026)

Takeda Pharmaceutical's Treasury Shares history runs 9 years deep, the most recent figure standing at $313.3 million for Q1 2026.

• On a quarterly basis, Treasury Shares fell 36.12% year-over-year to $313.3 million in Q1 2026; TTM through Mar 2026 was $313.3 million, a 36.12% decrease from a year earlier, with the FY2026 full-year figure at -$342.8 million, down 169.8% from the prior year.
• Treasury Shares grew to $313.3 million in Q1 2026 per TAK's latest filing, from -$335.3 million in the prior quarter.
• Across five years, Treasury Shares topped out at $274426.1 in Q1 2022 and bottomed at $92886.0 in Q1 2019.
• The 5-year median for Treasury Shares is $170904.3 (2020), against an average of $174247.0.
• Across the five-year window, Treasury Shares surged 96.44% in 2024 and plunged 2675.72% in 2025, its largest moves.
• Year by year, Treasury Shares stood at -$710.1 million in 2022, then jumped by 51.17% to -$346.7 million in 2023, then jumped by 52.89% to -$163.4 million in 2024, then slumped by 105.26% to -$335.3 million in 2025, then surged by 193.43% to $313.3 million in 2026.
• Per Business Quant, the three latest TAK Treasury Shares figures stand at $313.3 million (Q1 2026), -$335.3 million (Q4 2025), and -$350.2 million (Q3 2025).